FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Time-Cap Laboratories Ibuprofen Tablets Recall

Ibuprofen Tablets, USP, 200 mg, a) 50 tablet (NDC 53943-291-15), b) 100 tablet (NDC 539…

Time-Cap Laboratories, Inc. · Farmingdale, NY

Risk level
Class II
Reported by FDA
May 2, 2018
Recall ID
D-0686-2018
Check your lot numberHow we source this data

Summary

Time-Cap Laboratories recalled Ibuprofen Tablets starting Jan 11, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0686-2018 on May 2, 2018. Reason: CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies. Status: Terminated.

Why it was recalled

CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.

Product description

Ibuprofen Tablets, USP, 200 mg, a) 50 tablet (NDC 53943-291-15), b) 100 tablet (NDC 53943-291-12), c) 500 tablet (NDC 53943-291-14), Brown, Distributed by Drug Mart, Food Fair, Medina, Ohio 44256

Lot numbers, UPCs & expiration codes

a) D167C, exp 2/18, E135C, exp 3/18; b) D172C, exp 2/18; c) D167C, exp 2/18, E135C, exp 3/18

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0686-2018
Classification
Class II
Status
Terminated
Recall initiated
Jan 11, 2018
FDA report date
May 2, 2018
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Time-Cap Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0686-2018, exactly as published.

Show all FDA fields
City
Farmingdale
State
NY
Status
Terminated
Country
United States
Event ID
79349
Address
7 Michael Ave
Code information
a) D167C, exp 2/18, E135C, exp 3/18; b) D172C, exp 2/18; c) D167C, exp 2/18, E135C, exp 3/18
Postal code
11735-3921
Report date
May 2, 2018
Product type
Drugs
Recall number
D-0686-2018
Classification
Class II
Recalling firm
Time-Cap Laboratories, Inc.
Termination date
Jan 20, 2021
Reason for recall
CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ibuprofen Tablets, USP, 200 mg, a) 50 tablet (NDC 53943-291-15), b) 100 tablet (NDC 53943-291-12), c) 500 tablet (NDC 53943-291-14), Brown, Distributed by Drug Mart, Food Fair, Medina, Ohio 44256
Distribution pattern
Nationwide.
Recall initiation date
Jan 11, 2018
Initial firm notification
Letter
Center classification date
Apr 22, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0686-2018, published May 2, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls